Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:clinical_trial
|
| gptkbp:endDate |
safety concerns
|
| gptkbp:focus |
perfluorocarbon-based oxygen carrier
|
| https://www.w3.org/2000/01/rdf-schema#label |
Oxygent Clinical Trials
|
| gptkbp:indication |
prevention of hypoxia during surgery
|
| gptkbp:location |
gptkb:Europe
gptkb:United_States |
| gptkbp:period |
Phase III
|
| gptkbp:relatedTo |
Oxygent
|
| gptkbp:sponsor |
Alliance Pharmaceutical Corp.
|
| gptkbp:startYear |
late 1990s
|
| gptkbp:status |
terminated
|
| gptkbp:studiedDrug |
Oxygent
|
| gptkbp:yearTerminated |
early 2000s
|
| gptkbp:bfsParent |
gptkb:Artificial_Blood
|
| gptkbp:bfsLayer |
8
|